# Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

> **NCT07386587** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **University of Child Health Sciences and Children's Hospital, Lahore** · enrollment: 60 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered)

## Key facts

- **NCT ID:** NCT07386587
- **Lead sponsor:** University of Child Health Sciences and Children's Hospital, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-27
- **Primary completion:** 2026-07-27
- **Final completion:** 2026-07-27
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07386587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07386587, "Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07386587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*